YuanMing Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 7
Professionals
  • Investments
  • 23
  • Portfolio
  • 11
  • Exits
  • 5
Exits

YuanMing Capital General Information

Description

YuanMing Capital is a healthcare based venture capital firm headquartered in Beijing, China. The firm prefers to invest in the therapeutics, medical devices, diagnostics and healthcare service sectors. Its regional preference is US and China.

Contact Information

Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Room 1106, Tower B, China Waiwen Mansion
  • No.89 North of West Third Ring Road, Haidian District
  • Beijing, 100089
  • China

YuanMing Capital Investments (23)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Bayzed Healthcare 01-Jan-2021 Early Stage VC Hospitals/Inpatient Services Generating Revenue
00000 000000000 18-Nov-2020 00000 00000 00000 Drug Discovery Generating Revenue
00 000000000 02-Jul-2020 00000 00000 000.00 Drug Delivery Generating Revenue
000000000 000000 01-Mar-2020 00000 00000 0000 Pharmaceuticals Generating Revenue/Not Profitable
00 000000000000 09-May-2019 00000 00000 00000 Biotechnology Product Development
000000000 000000 17-Jul-2018 00000 00000 00000 Drug Discovery Generating Revenue/Not Profitable 00000000 0000 00.0
0000000 00000 0000 01-Jul-2018 00000 00000 00000 Decision/Risk Analysis Generating Revenue
00000 000000 26-Jun-2018 00000 00000 0000 Drug Discovery Clinical Trials - General
Mevion Medical Systems 14-Jun-2018 PE Growth/Expansion 00000 Therapeutic Devices Generating Revenue 0000 00 00.0
JW Therapeutics 24-May-2018 Early Stage VC 000.00 Biotechnology Product Development 00000000 0000 00.0
You’re viewing 10 of 23 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

YuanMing Capital Exits (5)

Company Name Exit Date Exit Type Exit Size
JW Therapeutics 03-Nov-2020 IPO 00000
000000000 000000 28-Oct-2019 000 000.00
000000000 (0000000 14-Nov-2018 0000000000: 000000
Edge Therapeutics 01-Oct-2015 IPO 000.00
ContraFect 12-Sep-2014 IPO 0000
To view YuanMing Capital’s complete exits history, request access »

YuanMing Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

YuanMing Capital Team (8)

Name Title Deals Funds Boards Office
Fiona Gong Managing Partner Beijing, China
Ken Li Managing Partner New York, NY
Mingzhang Li Managing Partner Beijing, China
Na Wu Managing Partner Beijing, China
Tina Yu Ph.D Managing Partner 0 Beijing, China
You’re viewing 5 of 8 team members. Get the full list »

YuanMing Capital Co-Investors (69)

Name With Exits Lead Partner Series Industry
3E Bioventures Capital 2 0 Series chart Industry bar
CCB International 0 0 Series chart Industry bar
Matrix Partners China 0 Series chart Industry bar
Sequoia Capital China 0 0 Series chart Industry bar
WuXi AppTec 0 0 Series chart Industry bar
You’re viewing 5 of 69 co-investors. Get the full list »